Literature DB >> 23583052

Epilepsy with myoclonic atonic seizures: an electroclinical study of 69 patients.

Roberto H Caraballo1, Noelia Chamorro, Francesca Darra, Sebastian Fortini, Hugo Arroyo.   

Abstract

Epilepsy with myoclonic-atonic seizures is characterized by myoclonic-atonic, absence, tonic-clonic, and eventually tonic seizures, appearing in previously normal children at ages 18-60 months. We analyzed the electroclinical features, treatment, and outcome of 69 patients with myoclonic-atonic seizures; these patients were followed between 1990 and 2012 at the Juan P. Garrahan Pediatric Hospital, Buenos Aires, Argentina. No structural or metabolic etiology was identified. Based on the electroclinical features and evolution, two groups could be distinguished. The first group of 39 patients with myoclonic and myoclonic-atonic seizures with or without generalized tonic-clonic seizures and absences associated with generalized spike- and polyspike-and-wave paroxysms had excellent prognoses. The second group of 30 patients had myoclonic jerks and myoclonic-atonic seizures associated with other seizure types including tonic seizures; some had myoclonic status epilepticus and cognitive deterioration. The interictal EEG showed frequent generalized spike- and polyspike-and-wave paroxysms. In 16 patients, the seizures remitted within 3.6 years. The two groups were distinguished in retrospect, when enough time had elapsed to evaluate cognitive deterioration and different seizure types. In conclusion, epilepsy with myoclonic atonic seizures is an epileptic syndrome with a broad clinical spectrum and variable prognosis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583052     DOI: 10.1016/j.pediatrneurol.2012.12.022

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  4 in total

1.  CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.

Authors:  Rhys H Thomas; Lin Mei Zhang; Gemma L Carvill; John S Archer; Sinéad B Heavin; Simone A Mandelstam; Dana Craiu; Samuel F Berkovic; Deepak S Gill; Heather C Mefford; Ingrid E Scheffer
Journal:  Neurology       Date:  2015-02-11       Impact factor: 9.910

2.  Clinical and genetic characteristics of patients with Doose syndrome.

Authors:  Nodoka Hinokuma; Mitsuko Nakashima; Hideyuki Asai; Kazuyuki Nakamura; Shinjiro Akaboshi; Masataka Fukuoka; Masami Togawa; Shingo Oana; Koyo Ohno; Mariko Kasai; Chikako Ogawa; Kazuna Yamamoto; Kiyohito Okumiya; Pin Fee Chong; Ryutaro Kira; Shumpei Uchino; Tetsuhiro Fukuyama; Tomoe Shinagawa; Yohane Miyata; Yuichi Abe; Akira Hojo; Kozue Kobayashi; Yoshihiro Maegaki; Nobutsune Ishikawa; Hiroko Ikeda; Masano Amamoto; Takeshi Mizuguchi; Kazuhiro Iwama; Toshiyuki Itai; Satoko Miyatake; Hirotomo Saitsu; Naomichi Matsumoto; Mitsuhiro Kato
Journal:  Epilepsia Open       Date:  2020-07-23

3.  Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.

Authors:  Krista Eschbach; Angela Moss; Charuta Joshi; Katie Angione; Garnett Smith; Amanda Dempsey; Elizabeth Juarez-Colunga; Scott T Demarest
Journal:  Epilepsy Res       Date:  2018-09-24       Impact factor: 3.045

Review 4.  Cognitive and neurodevelopmental comorbidities in paediatric epilepsy.

Authors:  Katherine C Nickels; Michael J Zaccariello; Lorie D Hamiwka; Elaine C Wirrell
Journal:  Nat Rev Neurol       Date:  2016-07-22       Impact factor: 42.937

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.